29 research outputs found
Effects of Task Experience and Layout on Learning from Text and Pictures with or without Unnecessary Picture Descriptions
The presentation of extraneous (i.e., irrelevant or unnecessary) information may
hamper learning with multimedia. The present study examined whether people can
learn to ignore unnecessary information with increasing experience with the task and
whether this depends on the layout of that information. In two experiments,
participants learned about the process of mitosis from a multimedia slideshow, with
each slide presenting a combination of expository text and a picture on one of the
stages in the process. Slides either contained no unnecessary text (control condition)
or unnecessary text (i.e., merely describing the picture) either integrated in the picture
(integrated condition) or presented underneath the picture (separated condition).
Knowledge about the studied mitosis phase was tested immediately after each slide
using a cloze test. Across Experiments 1 and 2, we did not find a reliable negative effect
of the unnecessary text on cloze test performance. As a result, the question of whether
task experience would reduce or eliminate that negative effect could not be answered.
The eye movement data did confirm, however, that participants attended less to the
unnecessary information with increasing task experience, suggesting that students
can adapt their study strategy and learn to ignore unnecessary information
Determination of nutrient salts by automatic methods both in seawater and brackish water: the phosphate blank
9 páginas, 2 tablas, 2 figurasThe main inconvenience in determining nutrients in seawater by automatic methods is simply solved:
the preparation of a suitable blank which corrects the effect of the refractive index change on the recorded
signal. Two procedures are proposed, one physical (a simple equation to estimate the effect) and the other
chemical (removal of the dissolved phosphorus with ferric hydroxide).Support for this work came from CICYT (MAR88-0245 project) and
Conselleria de Pesca de la Xunta de GaliciaPeer reviewe
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
The third edition of Flow Cytometry Guidelines provides the key aspects to consider when performing flow cytometry experiments and includes comprehensive sections describing phenotypes and functional assays of all major human and murine immune cell subsets. Notably, the Guidelines contain helpful tables highlighting phenotypes and key differences between human and murine cells. Another useful feature of this edition is the flow cytometry analysis of clinical samples with examples of flow cytometry applications in the context of autoimmune diseases, cancers as well as acute and chronic infectious diseases. Furthermore, there are sections detailing tips, tricks and pitfalls to avoid. All sections are written and peer‐reviewed by leading flow cytometry experts and immunologists, making this edition an essential and state‐of‐the‐art handbook for basic and clinical researchers.DFG, 389687267, Kompartimentalisierung, Aufrechterhaltung und Reaktivierung humaner Gedächtnis-T-Lymphozyten aus Knochenmark und peripherem BlutDFG, 80750187, SFB 841: Leberentzündungen: Infektion, Immunregulation und KonsequenzenEC/H2020/800924/EU/International Cancer Research Fellowships - 2/iCARE-2DFG, 252623821, Die Rolle von follikulären T-Helferzellen in T-Helferzell-Differenzierung, Funktion und PlastizitätDFG, 390873048, EXC 2151: ImmunoSensation2 - the immune sensory syste
Depsipeptides Featuring a Neutral P1 Are Potent Inhibitors of Kallikrein-Related Peptidase 6 with On-Target Cellular Activity
Kallikrein-related peptidase 6 (KLK6)
is a secreted serine protease
that belongs to the family of tissue kallikreins (KLKs). Many KLKs
are investigated as potential biomarkers for cancer as well as therapeutic
drug targets for a number of pathologies. KLK6, in particular, has
been implicated in neurodegenerative diseases and cancer, but target
validation has been hampered by a lack of selective inhibitors. This
work introduces a class of depsipeptidic KLK6 inhibitors, discovered
via high-throughput screening, which were found to function as substrate
mimics that transiently acylate the catalytic serine of KLK6. Detailed
structure–activity relationship studies, aided by in silico
modeling, uncovered strict structural requirements for potency, stability,
and acyl-enzyme complex half-life. An optimized scaffold, DKFZ-251,
demonstrated good selectivity for KLK6 compared to other KLKs, and
on-target activity in a cellular assay. Moreover, DKFZ-633, an inhibitor-derived
activity-based probe, could be used to pull down active endogenous
KLK6
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Invasion and metastasis of carcinomas is promoted by the activation of the embryonic 'epithelial to mesenchymal transition' (EMT) program, which triggers cellular mobility and subsequent dissemination of tumour cells. We recently showed that the EMT-activator ZEB1 (zinc finger E-box binding homeobox 1) is a crucial promoter of metastasis and demonstrated that ZEB1 inhibits expression of the microRNA-200 (miR-200) family, whose members are strong inducers of epithelial differentiation. Here, we report that ZEB1 not only promotes tumour cell dissemination, but is also necessary for the tumour-initiating capacity of pancreatic and colorectal cancer cells. We show that ZEB1 represses expression of stemness-inhibiting miR-203 and that candidate targets of miR-200 family members are also stem cell factors, such as Sox2 and Klf4. Moreover, miR-200c, miR-203 and miR-183 cooperate to suppress expression of stem cell factors in cancer cells and mouse embryonic stem (ES) cells, as demonstrated for the polycomb repressor Bmi1. We propose that ZEB1 links EMT-activation and stemness-maintenance by suppressing stemness-inhibiting microRNAs (miRNAs) and thereby is a promoter of mobile, migrating cancer stem cells. Thus, targeting the ZEB1-miR-200 feedback loop might form the basis of a promising treatment for fatal tumours, such as pancreatic cancer